| Medical and Health Sciences | Lifetime | 33 | DK 2 | 100.00 |
| Biological Sciences | Lifetime | 707 | DK 8 | 99.92 |
| Medical and Health Sciences | 2021-2025 | 237 | DK 5 | 99.95 |
| Endocrinology, Diabetes and Metabolism | Lifetime | 1 | DK 1 | 99.99 |
| Surgery | Lifetime | 19 | DK 4 | 99.98 |
| Medical Physiology | Lifetime | 106 | DK 4 | 99.84 |
| Cellular and Molecular Neuroscience | Lifetime | 122 | DK 2 | 99.59 |
| Epidemiology | Lifetime | 427 | DK 5 | 99.47 |
| Nutrition and Dietetics | Lifetime | 196 | DK 4 | 99.07 |
| Endocrine and Autonomic Systems | Lifetime | 62 | DK 1 | 98.92 |
| Oncology | Lifetime | 444 | DK 5 | 99.23 |
| Gastroenterology | Lifetime | 112 | DK 2 | 98.59 |
| Clinical Pharmacology | Lifetime | 450 | DK 8 | 98.12 |
| Cell Biology | Lifetime | 933 | DK 16 | 93.48 |
| Surgery | 2021-2025 | 49 | DK 3 | 99.71 |
| Endocrinology, Diabetes and Metabolism | 2021-2025 | 23 | DK 1 | 99.82 |
| Medical Physiology | 2021-2025 | 57 | DK 1 | 99.25 |
| Clinical Pharmacology | 2021-2025 | 146 | DK 4 | 94.97 |
| Molecular Biology | 2021-2025 | 879 | DK 10 | 95.13 |
| Endocrine and Autonomic Systems | 2021-2025 | 71 | DK 2 | 90.96 |
| Management of Technology and Innovation | 2021-2025 | 381 | DK 7 | 66.16 |
| Pancreatic function and diabetes | Lifetime | 1 | DK 1 | 99.99 |
| Diabetes Treatment and Management | Lifetime | 1 | DK 1 | 99.99 |
| Diet and metabolism studies | Lifetime | 3 | DK 1 | 99.98 |
| Diabetes Management and Research | Lifetime | 2 | DK 1 | 99.95 |
| Metabolism, Diabetes, and Cancer | Lifetime | 2 | DK 1 | 99.95 |
| Peptidase Inhibition and Analysis | Lifetime | 4 | DK 1 | 99.97 |
| Neuroendocrine Tumor Research Advances | Lifetime | 4 | DK 1 | 99.91 |
| Bariatric Surgery and Outcomes | Lifetime | 2 | DK 1 | 99.80 |
| Neuropeptides and Animal Physiology | Lifetime | 6 | DK 1 | 99.96 |
| Pharmacology and Obesity Treatment | Lifetime | 2 | DK 2 | 99.89 |
| Diet, Metabolism, and Disease | Lifetime | 10 | DK 1 | 99.88 |
| Regulation of Appetite and Obesity | Lifetime | 5 | DK 1 | 99.91 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | Lifetime | 7 | DK 1 | 99.71 |
| Gastroesophageal reflux and treatments | Lifetime | 23 | DK 1 | 99.72 |
| Clinical Nutrition and Gastroenterology | Lifetime | 37 | DK 2 | 99.41 |
| Receptor Mechanisms and Signaling | Lifetime | 114 | DK 2 | 99.56 |
| Diabetes and associated disorders | Lifetime | 87 | DK 1 | 99.40 |
| Gastrointestinal motility and disorders | Lifetime | 45 | DK 1 | 99.48 |
| Pharmaceutical studies and practices | Lifetime | 58 | DK 1 | 99.15 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 138 | DK 1 | 99.27 |
| Cardiovascular, Neuropeptides, and Oxidative Stress Research | Lifetime | 23 | DK 2 | 98.91 |
| Adipose Tissue and Metabolism | Lifetime | 246 | DK 12 | 99.31 |
| Biochemical Analysis and Sensing Techniques | Lifetime | 137 | DK 2 | 98.69 |
| Digestive system and related health | Lifetime | 86 | DK 3 | 98.60 |
| Muscle metabolism and nutrition | Lifetime | 290 | DK 18 | 98.48 |
| Pancreatitis Pathology and Treatment | Lifetime | 501 | DK 3 | 97.82 |
| Infant Nutrition and Health | Lifetime | 305 | DK 5 | 97.35 |
| Vagus Nerve Stimulation Research | Lifetime | 68 | DK 1 | 97.00 |
| Apelin-related biomedical research | Lifetime | 138 | DK 3 | 95.85 |
| Pharmacological Effects and Assays | Lifetime | 392 | DK 7 | 95.40 |
| Dietary Effects on Health | Lifetime | 439 | DK 3 | 92.95 |
| Enhanced Recovery After Surgery | Lifetime | 582 | DK 29 | 91.20 |
| Diet and metabolism studies | 2021-2025 | 11 | DK 1 | 99.75 |
| Pancreatic function and diabetes | 2021-2025 | 10 | DK 1 | 99.71 |
| Regulation of Appetite and Obesity | 2021-2025 | 4 | DK 1 | 99.09 |
| Diabetes Treatment and Management | 2021-2025 | 29 | DK 1 | 99.71 |
| Metabolism, Diabetes, and Cancer | 2021-2025 | 20 | DK 1 | 99.31 |
| Neuropeptides and Animal Physiology | 2021-2025 | 15 | DK 3 | 97.64 |
| Pharmacology and Obesity Treatment | 2021-2025 | 11 | DK 1 | 98.69 |
| Diabetes Management and Research | 2021-2025 | 89 | DK 2 | 98.60 |
| Bariatric Surgery and Outcomes | 2021-2025 | 56 | DK 1 | 97.34 |
| Diet, Metabolism, and Disease | 2021-2025 | 82 | DK 3 | 97.42 |
| Receptor Mechanisms and Signaling | 2021-2025 | 307 | DK 9 | 90.31 |
| Gastrointestinal motility and disorders | 2021-2025 | 421 | DK 9 | 87.14 |
| Biochemical Analysis and Sensing Techniques | 2021-2025 | 652 | DK 8 | 81.50 |
| Hyperglycemia and glycemic control in critically ill and hospitalized patients | 2021-2025 | 292 | DK 12 | 80.57 |
| Gastroesophageal reflux and treatments | 2021-2025 | 730 | DK 3 | 81.50 |
| Dietary Effects on Health | 2021-2025 | 468 | DK 9 | 77.24 |
| Digital Innovation in Industries | 2021-2025 | 95 | DK 1 | 73.34 |
| Digestive system and related health | 2021-2025 | 699 | DK 29 | 64.04 |
| GDF15 and Related Biomarkers | 2021-2025 | 800 | DK 12 | 47.06 |
| Apelin-related biomedical research | 2021-2025 | 857 | DK 6 | 24.89 |